Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancer

Oncology Letters

Volumn 1, Issue 3, 2010, Pages 515-519

  Shoji, Tadahiro ^a   Takatori, Eriko ^a   Hatayama, Shinya ^a   Omi, Hideo ^a   Kagabu, Masahiro ^a   Honda, Tatsuya ^a   Kumagai, Seisuke ^a   Morohara, Yuichi ^a   Miura, Fumiharu ^a   Yoshizaki, Akira ^a   Sugiyama, Toru ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Cisplatin; Irinotecan; Neoadjuvant chemotherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; RADICAL HYSTERECTOMY; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VOMITING;

EID: 77955728768     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000091     Document Type: Article

References (19)

1. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
2. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153, 1999.
3. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL and Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17: 1339-1348, 1999.
4. Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G and Tu D: Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20: 966-972, 2002.
5. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch: DG Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22: 872-880, 2004.
6. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M and Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358: 781-786, 2001.
7. Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, Fung MF and Browman G: Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. J Clin Oncol 14: 203-212, 2002.
8. Sugiyama T, Nishida T, Kumagai S, Nishino S, Fujivoshi K, Okura N, Yakushiji M, Hiura M and Umesaki N: Combination chemotherapy with irinotecan and cisplatin as neoadjuvant in locally advanced cervical cancer. Br J Cancer 81: 95-98, 1999.
9. Sugiyama T, Nishida T, Kataoka A, Imaishi K, Komai K, Ushijima K, Hasuo Y, Ookura N and Yakushiji M: Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer. Acta Obstet Gynecol Japan 48: 827-834, 1996.
10. Takeuchi S, Dobashi K, Fujimoto S, et al: A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers. Gan To Kagaku Ryoho 18: 1861-1689, 1991.
11. Sugiyama T, Yakushiji M, Noda K, Ikeda M, Kudoh R, Yajima A, Tomoda Y, Terashima Y, Takeuchi S, Hiura M, Saji F, Takahashi T, Umesaki N, Sato S, Hatae M and Ohashi Y: Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer. Oncology 58: 31-37, 2000.
12. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L and Major FJ: Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 3: 1079-1085, 1985.
13. Rose PG, Blessing JA, Gershenson DM and McGehee R: Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 17: 2676-2680, 1999.
14. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF and Rocereto TF: Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 22: 3113-3119, 2004.
15. Takeuchi S, Noda K, Yakushiji M and CPT-11 Study Group on Gynecologic Malignancy: Late phase II study of CPT-11, topoisomerase I inhibitor, in advance cervical carcinoma (CC). Proc Am Soc Clin Oncol 11: 224, 1992.
16. Tierney J: Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39: 2470-2486, 2003.
17. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C and Landoni F: Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian Multicenter Randomized study. J Clin Oncol 20: 179-188, 2002.
18. Napolitano C, Imperato F, Mossa B, Framarino ML, Marziani R and Marzetti L: The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaec Oncol 14: 51-59, 2002.
19. Huang HJ, Chang TC, Hong JH, Tseng CJ, Chou HH, Huang K KG and Lai CH: Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 13: 204-211, 2003.